Protective effects of low-frequency magnetic fields on cardiomyocytes from ischemia reperfusion injury via ROS and NO/ONOO-

Oxid Med Cell Longev. 2013:2013:529173. doi: 10.1155/2013/529173. Epub 2013 Nov 7.

Abstract

Background: Cardiac ischemia reperfusion (I/R) injury is associated with overproduction of reactive oxygen species (ROS). Low frequency pulse magnetic fields (LFMFs) have been reported to decrease ROS generation in endothelial cells. Whether LFMFs could assert protective effects on myocardial from I/R injury via ROS regulation remains unclear.

Methods: To simulate in vivo cardiac I/R injury, neonatal rat cardiomyocytes were subjected to hypoxia reoxygenation (H/R) with or without exposure to LFMFs. Cell viability, apoptosis index, ROS generation (including O2(-) and ONOO(-)), and NO production were measured in control, H/R, and H/R + LFMF groups, respectively.

Results: H/R injury resulted in cardiomyocytes apoptosis and decreased cell viability, whereas exposure to LFMFs before or after H/R injury significantly inhibited apoptosis and improved cell viability (P < 0.05). LFMFs treatment could suppress ROS (including O2(-) and ONOO(-)) generation induced by H/R injury, combined with decreased NADPH oxidase activity. In addition, LFMFs elevated NO production and enhanced NO/ONOO(-) balance in cardiomyocytes, and this protective effect was via the phosphorylation of endothelial nitric oxide synthase (eNOS).

Conclusion: LFMFs could protect myocardium against I/R injury via regulating ROS generation and NO/ONOO(-) balance. LFMFs treatment might serve as a promising strategy for cardiac I/R injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cardiotonic Agents / metabolism*
  • Cell Hypoxia / drug effects
  • Cell Separation
  • Cell Survival / drug effects
  • Cells, Cultured
  • Magnetic Fields*
  • Myocardial Reperfusion Injury / enzymology
  • Myocardial Reperfusion Injury / pathology*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / enzymology
  • Myocytes, Cardiac / pathology*
  • NADPH Oxidases / metabolism
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type II / metabolism
  • Nitric Oxide Synthase Type III / metabolism
  • Oxygen / pharmacology
  • Peroxynitrous Acid / metabolism*
  • Phosphorylation / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism*

Substances

  • Cardiotonic Agents
  • Reactive Oxygen Species
  • Peroxynitrous Acid
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • NADPH Oxidases
  • Oxygen